75例冠心病患者血清脂蛋白(a)的检测分析  

Clinical valuation of the detection of serum lipoprotein (a) from the patients with coronary heart disease

作　　者：薛丽[1] 刘定海[1] 刘利洪[1] 李敬[1] 

机构地区：[1]四川省德阳市人民医院,618000

出　　处：《检验医学与临床》2009年第22期1914-1914,1916,共2页Laboratory Medicine and Clinic

摘　　要：目的探讨血清脂蛋白(a)[Lp(a)]在冠心病患者中的变化和作用。方法采用免疫透射比浊法测定冠心病患者和健康对照者血清Lp(a)水平。结果冠心病患者血清Lp(a)水平明显高于健康对照组,分别为(0.368±0.176)、(0.155±0.110)g/L,差异有统计学意义(P<0.01)。结论血清Lp(a)水平的升高与冠心病的发生密切相关,在冠心病的临床诊断和治疗预后中具有重要价值。Objective To probe into the serum lipoprotein （a） changes and the function of the patients with coronary heart disease. Methods Adopt the serum lipoprotein（a） from the determined heart disease patient and the healthy control group respectively. Results The level of the serum lipoprotein （a） of coronary heart disease patients is obviously higher than that of the health control group （0. 368±0. 176 and 0. 155± 0. 110 g/L） ;As a result, there is a significant difference（P〈0.01）. Conclusion The rising of the level of serum lipoprotein（a） in the patients is closely related to the emergence of coronary heart disease, so it is of great importance in the clinical diagnosis and prognosis as well as treatment of coronary heart disease.

关 键 词：脂蛋白(a) 冠心病 免疫比浊法 

分 类 号：R446.1[医药卫生—诊断学] R541.4[医药卫生—临床医学]